Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) EBITDA (2016 - 2025)

Historic EBITDA for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $1.9 million.

  • Axogen's EBITDA rose 70506.33% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 14636.39%. This contributed to the annual value of -$3.3 million for FY2024, which is 8468.46% up from last year.
  • Per Axogen's latest filing, its EBITDA stood at $1.9 million for Q3 2025, which was up 70506.33% from $1.7 million recorded in Q2 2025.
  • Axogen's EBITDA's 5-year high stood at $2.0 million during Q4 2024, with a 5-year trough of -$11.3 million in Q1 2022.
  • In the last 5 years, Axogen's EBITDA had a median value of -$4.9 million in 2022 and averaged -$4.1 million.
  • In the last 5 years, Axogen's EBITDA crashed by 54009.57% in 2021 and then soared by 70506.33% in 2025.
  • Axogen's EBITDA (Quarter) stood at -$5.4 million in 2021, then fell by 4.76% to -$5.6 million in 2022, then skyrocketed by 43.05% to -$3.2 million in 2023, then skyrocketed by 163.15% to $2.0 million in 2024, then fell by 5.21% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $1.7 million for Q2 2025, and -$1.7 million during Q1 2025.